EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Autocrine Transforming Growth Factor-β Signaling Promotes Cell Motility and Chemokine Secretion in an Angiomyolipoma-Derived Cell Model of Lymphangioleiomyomatosis

Anna Moskal, Rafał Myrczek, Mateusz Wawro, Lara R Auladell, Alexandra Baiges, Irene Garcia, Francesca M Gonzalez, Miquel A Pujana, Jakub Kochan, Alicja Hinz, Elżbieta Radzikowska, Sophie Lucas und 2 weitere

The American Journal of Pathology · 2025

DOI: 10.1016/j.ajpath.2025.04.019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Pathology, 2025. Verfasst von Anna Moskal und 13 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland. Hauptthemen laut MEDLINE: Lymphangioleiomyomatosis, Cell Movement, Transforming Growth Factor beta, Angiomyolipoma. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund, Instituto de Salud Carlos III, CERCA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lymphangioleiomyomatosis (LAM) is a rare systemic disease that affects young women and is classified as a low-grade metastasizing neoplasm. It is characterized by uncontrolled proliferation of LAM cells within the lung parenchyma, which results from loss-of-function mutations in tuberous sclerosis complex 2 (TSC2) or 1 (TSC1) and activation of the mechanistic target of rapamycin complex 1. Abnormal cell growth leads to cyst formation and lung damage. Rapamycin-based therapy is the only approved treatment. Although it stabilizes the lung function in most patients, it has several limitations. Therefore, new therapeutic strategies are needed. This study examined the role of transforming growth factor-β (TGF-β), a pleiotropic cytokine with well-established protumorigenic activity, in LAM cell biology. Using a TSC2-deficient angiomyolipoma-derived cell line indicated that TSC2-/- cells exhibited a higher expression of TGFβ1 and TGFβ3 than cells with restored TSC2 expression. Additionally, TSC2-/- cells expressed glycoprotein-A repetitions predominant and integrin β8, which promote TGF-β activation. Inhibition of TGF-β signaling in TSC2-/- cells reduced their migration in a wound healing assay, impaired transmigration through a three-dimensional matrix, and decreased the expression of monocyte chemoattractant protein-1. These findings provide new insights into the regulation of processes contributing to LAM progression and point to TGF-β as one of the potential targets for LAM treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphangioleiomyomatosisCell MovementTransforming Growth Factor betaAngiomyolipomaChemokinesAutocrine CommunicationLung NeoplasmsHumansTuberous Sclerosis Complex 2 ProteinSignal TransductionFemaleCell Line, Tumor

Substanzen

Tuberous Sclerosis Complex 2 ProteinTransforming Growth Factor betaTSC2 protein, humanChemokines

Autor:innen und Institutionen

  • Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
  • ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Spain.
  • ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Spain; Girona Institute for Biomedical Research (IDIBGI), Salt, Spain.
  • Department of Lung Diseases III, National Tuberculosis and Lung Disease Research Institute, Warsaw, Poland.
  • de Duve Institute, UCLouvain, Brussels, Belgium.
  • Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland. Electronic address: renata.mezyk-kopec@uj.edu.pl.

Förderung

  • European Regional Development Fund
  • Instituto de Salud Carlos III
  • CERCA
  • National Science Centre Poland
  • Generalitat de Catalunya
  • Fundació la Marató de TV3
  • Jagiellonian University in Kraków
  • Uniwersytet Jagielloński Collegium Medicum

Zitieren

APA

Moskal, A., Myrczek, R., Wawro, M., Auladell, L. R., Baiges, A., Garcia, I., Gonzalez, F. M., Pujana, M. A., Kochan, J., Hinz, A., Radzikowska, E., Lucas, S., Bereta, J., & Mezyk-Kopec, R. (2025). Autocrine Transforming Growth Factor-β Signaling Promotes Cell Motility and Chemokine Secretion in an Angiomyolipoma-Derived Cell Model of Lymphangioleiomyomatosis. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2025.04.019

Vancouver

Moskal A, Myrczek R, Wawro M, Auladell LR, Baiges A, Garcia I, et al. Autocrine Transforming Growth Factor-β Signaling Promotes Cell Motility and Chemokine Secretion in an Angiomyolipoma-Derived Cell Model of Lymphangioleiomyomatosis. The American Journal of Pathology. 2025. doi:10.1016/j.ajpath.2025.04.019

BibTeX
@article{Moskal2025,
  author = {Moskal, Anna and Myrczek, Rafał and Wawro, Mateusz and Auladell, Lara R and Baiges, Alexandra and Garcia, Irene and Gonzalez, Francesca M and Pujana, Miquel A and Kochan, Jakub and Hinz, Alicja and Radzikowska, Elżbieta and Lucas, Sophie and Bereta, Joanna and Mezyk-Kopec, Renata},
  title = {Autocrine Transforming Growth Factor-β Signaling Promotes Cell Motility and Chemokine Secretion in an Angiomyolipoma-Derived Cell Model of Lymphangioleiomyomatosis},
  journal = {The American Journal of Pathology},
  year = {2025},
  doi = {10.1016/j.ajpath.2025.04.019}
}
Kostenlos starten →